GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit
Provided By PR Newswire
Last update: Feb 12, 2025
NEW YORK, Feb. 12, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between February 5, 2020 and August 14, 2022, both dates inclusive (the "Class Period"), of the important April 7, 2025 lead plaintiff deadline.
Read more at prnewswire.com
